Position in LEXX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,540
+$10,540 QoQ
Shares Held
13,513
-14.8% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEXX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $5,531,283,955 across 373 Biotechnology names. LEXX ranks #353 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,182,571 | $356,894,009 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,032,298 | $306,561,536 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
4,512,634 | $254,918,694 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,259,444 | $238,097,887 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
453,843 | $237,573,195 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,173,940 | $235,696,783 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
1,551,900 | $163,570,260 | |
| 8 | ARGX |
Argenx SE
|
219,126 | $160,016,761 |
All Filings in LEXX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,540 | 13,513 | Shares | Defined | 2026-05-15 | |
| 2024-03-31 | — | 15,856 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | — | 29,561 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | — | 18,674 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | — | 24,874 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | — | 27,888 | Shares | Defined | 2022-08-15 | |
| 2021-03-31 | $83,673 | 14,915 | Shares | Defined | 2021-05-21 | |
| No filing history on record for this holder in this stock. | ||||||